Scorpius HoldingsSCPX Days Payable is 2,907.81 as of Sep. 2025, which is 424% above its 10-year median of 555.03. The stock has 7 warning signs investors should review. Among 707 Biotechnology companies, Scorpius Holdings ranks better than 86.85% on this metric.
The historical rank and industry rank for Scorpius Holdings's Days Payable or its related term are showing as below:
SCPX'
s Days Payable Range Over the Past 10 Years
Min: 418.96 Med: 555.03 Max: 11574.1
Current: 1087.22
During the past 13 years, Scorpius Holdings's highest Days Payable was 11574.10. The lowest was 418.96. And the median was 555.03.
SCPX's Days Payable is ranked better than 86.85% of 707
companies
in the Biotechnology industry
Industry Median: 113.76
vs SCPX: 1087.22
Scorpius Holdings's Days Payable
increased
from Sep. 2024 (332.66) to Sep. 2025 (2,907.81).
It may suggest that Scorpius Holdingsdelayed paying its suppliers.
Scorpius Holdings Days Payable Related Terms
Scorpius Holdings Days Payable Historical Data
* Premium members only.
The historical data trend for Scorpius Holdings's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Scorpius Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Scorpius Holdings Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Scorpius Holdings's Days Payable distribution charts can be found below:
* The bar in red indicates where Scorpius Holdings's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Scorpius Holdings's Days Payable for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Scorpius Holdings (SCPX) has a Days Payable of 2,907.81 as of Sep. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Scorpius Holdings and its competitors. This is 424% above median its historical median of 555.03. Over the past decade, Scorpius Holdings' Days Payable has ranged from 418.96 to 11,574.10. According to the industry distribution chart, Scorpius Holdings ranks #93 out of 707 companies in the Biotechnology industry, placing it in the top 13.2%.
Is Scorpius Holdings' Days Payable too high?
Scorpius Holdings' current Days Payable of 2,907.81 is 424% above median its 10-year median of 555.03. Over the past 10 years, this metric has ranged from a low of 418.96 to a high of 11,574.10. The Biotechnology industry median Days Payable is 113.76. Scorpius Holdings' value of 2,907.81 is 2456.1% above this industry median. Based on the distribution chart, Scorpius Holdings ranks #93 out of 707 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers.
How does Scorpius Holdings' Days Payable compare to ADTX and SIGY?
According to the Biotechnology industry distribution chart, Scorpius Holdings ranks #93 out of 707 companies for Days Payable. This places Scorpius Holdings in the top 13% of its industry — outperforming the majority of peers. The industry median Days Payable is 113.76. Scorpius Holdings' value of 2,907.81 is 2456.1% above this benchmark. Historically, Scorpius Holdings' own Days Payable has ranged from 418.96 to 11,574.10 over the past decade. While the company's 10-year median is 555.03 vs. the industry median of 113.76, Scorpius Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.76, based on 707 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Scorpius Holdings's current Days Payable of 2,907.81 is 2456.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Scorpius Holdings and its competitors. For the Biotechnology industry, the median Days Payable is 113.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Scorpius Holdings's current Days Payable is 2,907.81, which is 424% above median its own 10-year median of 555.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scorpius Holdings stock overvalued right now?
Based on GuruFocus' analysis, Scorpius Holdings (SCPX) is currently considered Possible Value Trap. The stock's GF Value™ is $0.14, compared to a current price of $0.01 — trading 96% below its estimated fair value. The current Days Payable is 2,907.81, which is 424% above median its 10-year median of 555.03 and 2456.1% above the Biotechnology industry median of 113.76. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Scorpius Holdings (SCPX), the current Days Payable is 2,907.81 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Scorpius Holdings Inc is an integrated contract development and manufacturing organization (CDMO) focused on rapidly advancing biologic and cell therapy programs to the clinic and beyond. It offers a broad array of analytical testing, process development, and manufacturing services to pharmaceutical and biotech companies at its state of the art facilities.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SCPX has been successfully added to your 